Business
Issue of New Ordinary Shares
Issue of New Ordinary Shares.
About this update from Sealand Capital Galaxy Ltd.
[{"type":"text","content":"\n \n \n \n RNS Number : 6464G\n Sealand Capital Galaxy Limited\n 30 March 2022\n \n \n \n \n Sealand Capital Galaxy Limited \n \n \n (\"Sealand\" or \"the Company\")\n \n \n \n \n \n Issue of New Ordinary Shares\n \n \n \n \n \n Sealand Capital Galaxy Limited (LSE: SCGL) announces that it has \n issued 4,909,091 new ordinary shares in lieu of professional services provided.\n \n \n \n \n \n Application will be made for the 4,909,091 new ordinary shares to be admitted to trading which is expected to be on or around 4 April 2022. The new ordinary shares will rank pari passu with the existing ordinary shares of the Company. \n \n \n \n \n \n Following the issue of the new ordinary shares, the Company's issued share capital will comprise of 600,603,476 ordinary shares. This figure of 600,603,476 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\n \n \n \n \n \n -Ends-\n \n \n \n \n \n \n \n \n \n Enquiries:\n \n \n \n \n \n \n \n \n \n \n \n \n Sealand Capital Galaxy Limited \n \n \n \n \n \n \n \n \n \n Law Chung Lam Nelson, Executive Chairman\n \n \n \n \n \n + 44 (0) 753 795 9788\n \n \n \n \n \n \n Novum Securities Limited \n \n \n \n \n \n \n \n \n \n David Coffman\n \n \n \n \n + 44 (0) 20 7399 9400\n \n \n \n \n \n \n \n \n \n Notes to Editors:\n \n \n The Company's Shares are traded on the Official List of the London Stock Exchange's main market for listed securities under the ticker SCGL.\n \n \n \n \n \n Further information on Sealand is available on its website \n \n \n http://www.scg-ltd.com/\n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and...